联合O-RADS MRI与ADCmean测量提升附件病变定性诊断效能
前瞻性纳入90例因附件病变行盆腔MRI的女性,共分析116个病变(良性71、恶性45)。以病理或随访为参考,O-RADS MRI评分>3与ADCmean≤1.08×10⁻³ mm²/s联合阈值较单纯O-RADS MRI显著提高特异度(97.1% vs 87.3%,p=0.005)和PPV(95.4% vs 83%,p=0.002),减少假阳性,敏感度及AUC无显著变化。
要点
- O-RADS MRI评分>3联合ADCmean≤1.08×10⁻³ mm²/s可显著提高附件病变恶性诊断特异度至97.1%,减少假阳性。
- 联合阈值下敏感度93.3%、PPV 95.4%、PLR 33.1,AUC 0.953,与单纯O-RADS MRI的AUC 0.926无显著差异。
- ADCmean单独阈值≤1.08×10⁻³ mm²/s的AUC 0.823、敏感度95.5%、特异度68%,可作为O-RADS MRI的辅助指标。
核心结论
- 在O-RADS MRI评分基础上加入ADCmean测量可减少附件病变假阳性、提高特异度和PPV,同时保持良好敏感度,诊断效能得到改善。
研究设计与样本
- 前瞻性研究纳入90例因附件病变行盆腔MRI的女性,共分析116个病变(良性71个、恶性45个)。
- 两名阅片者独立及共识进行O-RADS MRI评分,第三名阅片者计算ADCmean。
- 最终诊断由组织病理学(n=77)或随访影像(n=13)确定。
- 计算O-RADS MRI评分、ADCmean及联合阈值的AUC和诊断性能指标,P<0.05为显著。
诊断标准与关键数值
- 预测恶性附件病变的最佳O-RADS MRI阈值为评分>3,AUC 0.926,敏感度97.7%,特异度87.3%,PPV 83%,PLR 7.7。
- ADCmean最佳阈值为≤1.08×10⁻³ mm²/s,AUC 0.823,敏感度95.5%,特异度68%,PPV 66.2%,PLR 3.08。
- 联合阈值O-RADS MRI>3/ADCmean≤1.08×10⁻³ mm²/s:特异度97.1%(p=0.005)、PPV 95.4%(p=0.002)、PLR 33.1(p<0.0001)较单纯O-RADS MRI显著提高;AUC 0.953(p=0.252)、敏感度93.3%(p=0.467)无显著变化。
临床应用与阅片要点
- 对O-RADS MRI评分>3的附件病变,可加测ADCmean,若≤1.08×10⁻³ mm²/s则进一步提高恶性诊断特异度,减少假阳性。
- ADCmean单独诊断特异度较低(68%),不宜单独用于定性,需结合O-RADS MRI评分综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Evaluate the impact of adding mean apparent diffusion coefficient (ADCmean) measurements to the Ovarian-Adnexal Imaging Reporting and Data System MRI (O-RADS MRI) scoring for adnexal lesion characterization using a combined O-RADS MRI/ADCmean reading approach.
MATERIALS AND METHODS: This prospective study included 90 women who underwent pelvic MRI for adnexal lesions diagnosis and characterization. Two readers scored the adnexal lesions using the O-RADS MRI scoring independently and in consensus. A third reader calculated ADCmean measurements. The final diagnoses were determined by histo-pathology (n = 77) or follow-up imaging (n = 13). Areas under the curves (AUCs) and diagnostic performance metrics were calculated for the O-RADS MRI scoring, ADCmean, and combined O-RADS MRI/ADCmean thresholds. P-value <0.05 was significant.
RESULTS: 116 adnexal lesions (71 benign, 45 malignant) were analyzed. The optimal thresholds to predict malignant adnexal lesions were O-RADS MRI score >3 and ADCmean value ≤1.08 × 10-3 mm2/s (AUC 0.926 and 0.823; sensitivity 97.7% and 95.5%; specificity 87.3% and 68%; positive predictive value (PPV) 83% and 66.2%; positive likelihood ratio (PLR) 7.7 and 3.08, respectively). Compared to the O-RADS MRI scoring, a combined threshold of O-RADS MRI >3/ADCmean ≤1.08 × 10-3 mm2/s, yielded a reduction of false positives, a significant increase in the specificity (97.1%, p = 0.005), PPV (95.4%, p = 0.002), and PLR (33.1, p <0.0001), and non-significant change in the AUC (0.953, p = 0.252), and sensitivity (93.3%, p = 0.467).
CONCLUSION: The diagnostic performance of O-RADS MRI scoring to characterize adnexal lesions could be improved by adding the ADCmean values through reducing false positives, increasing specificity, and maintaining good sensitivity.
引用
- Elshetry, Hamed, Frere, et al. Impact of Adding Mean Apparent Diffusion Coefficient (ADCmean) Measurements to O-RADS MRI Scoring For Adnexal Lesions Characterization: A Combined O-RADS MRI/ADCmean Approach. Acad Radiol. 2022. PMID: 36085271. doi:10.1016/j.acra.2022.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。